AiBo Medical has successfully listed on the Science and Technology Innovation Board, marking a significant opportunity for growth in the ophthalmic medical device market.

Target Company Overview

AiBo Medical Technology Co., Ltd. (known as AiBo Medical) is a leading enterprise specializing in the research, development, production, and sale of ophthalmic medical devices. Their main product lines focus on surgical and vision correction solutions, particularly for prevalent eye diseases such as cataracts and refractive errors. Notably, AiBo Medical offers advanced products like foldable aspheric intraocular lenses that boast proprietary rights, breaking the domination of imported technologies in the high-end artificial lens market.

Recently, AiBo Medical successfully launched an initial public offering on the Science and Technology Innovation Board, solidifying its position as a trailblazer in the ophthalmic medical device sector. This strategic entry into the capital market is expected to propel the company forward in its commitment to innovation and product development.

Industry Overview

The ophthalmic medical device industry in China is experiencing significant growth, driven by increasing prevalence rates of eye diseases and a rising aging population. According to a report from Alcon, a global leader in the field, the market for ophthalmic medical devices reached approximately $23 billion globa